Regarding: 'High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'
- PMID: 19997112
- PMCID: PMC2795433
- DOI: 10.1038/sj.bjc.6605455
Regarding: 'High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series'
Comment on
-
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series.Br J Cancer. 2009 Jul 7;101(1):19-26. doi: 10.1038/sj.bjc.6605116. Epub 2009 Jun 9. Br J Cancer. 2009. PMID: 19513068 Free PMC article.
References
-
- Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B (2009) A multi-institutional evaluation of active surveillance for low risk prostate cancer. J Urol 181: 1635–1641 - PMC - PubMed
-
- Eggener SE, Scardino PT, Carroll PR, Zelefsky MJ, Sartor O, Hricak H, Wheeler TM, Fine SW, Trachtenberg J, Rubin MA, Ohori M, Kuroiwa K, Rossignol M, Abenhaim L (2007) Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities. J Urol 178: 2260–2267 - PubMed
-
- Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71–96 - PubMed
-
- Nielsen ME, Makarov DV, Humphreys E, Mangold L, Partin AW, Walsh PC (2008) Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion—‘nadir + 2’? Urology 72: 389–393 - PubMed